The multifaceted actions of VIP make it a promising target for therapeutic applications in various conditions, such as gastrointestinal disorders, inflammatory diseases, and neurological conditions
In addition, for longer storage, hold it at -20 C
DSIP is a nonapeptide with the formula CHNO and a molecular weight of 848.82 Da
A 2026 UK review of the May 2026 UCSF Annals of Neurology study showing "normal" but lower active B12 is linked to slower thinking and more white-matter brain injury, NICE NG239, the homocysteineDNA-methylation mechanism that suppresses hippocampal neurotrophins, the VITACOG brain-atrophy trial, pernicious anaemia, metformin and PPI depletion and why replacing the B12 comes first, not a peptide Read the full review Metabolic Neuropsychiatry & Cognitive Health 20 May 2026 Dihexa & GLP-1 Drugs (Ozempic, Wegovy, Mounjaro) and the Brain: The 2026 UK Review Do GLP-1 drugs like Ozempic, Wegovy and Mounjaro protect the brain or cause brain fog
[DOI] [PMC free article] [PubMed] [Google Scholar] 177.Nguyen MT, Satoh H, Favelyukis S, Babendure JL, Imamura T, Sbodio JI, et al